0.86% 0.11

Atara Biotherapeutics Inc (ATRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ATRA? Forum Prognose

Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	82.09% 17.57	98.15	32.75	40.19	28.64
Operating Expenses	75.77% 14.38	59.35	44.96	61.95	46.87
Interest Income/Expense	4.42% 0.972	1.017	1.017	1.183	1.262
Benefits Costs and Expenses	74.75% 15.19	60.14	45.47	62.12	47.69
Costs And Expenses	75.77% 14.38	59.35	44.96	61.95	46.87
Depreciation and Amortization	86.85% 0.236	1.795	1.10	1.23	1.33
Operating Income/Loss	91.76% 3.197	38.80	-12.20	-21.76	-18.23
Income/Loss From Continuing Operations Before Tax	93.71% 2.39	38.01	-12.71	-21.93	-19.05
Income Tax Expense/Benefit	0.003	-	-0.019	-0.017	-
Income/Loss From Continuing Operations After Tax	93.72% 2.387	38.01	-12.69	-21.91	-19.05
Net Income/Loss	93.72% 2.387	38.01	-12.69	-21.91	-19.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	13.31% 12.20	10.76	1.074	7.466	6.143
Diluted Average Shares	13.45% 12.31	10.85	1.074	7.466	6.143
Basic Earnings Per Share	94.33% 0.20	3.53	-0.07	-2.93	-3.10
Diluted Earnings Per Share	94.57% 0.19	3.50	-0.07	-2.93	-3.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%